Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 1 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 9 |
Descriptor
| Stimulants | 9 |
| Drug Therapy | 7 |
| Children | 6 |
| Attention Deficit… | 5 |
| Attention Deficit Disorders | 4 |
| Hyperactivity | 4 |
| Body Height | 3 |
| Body Weight | 3 |
| Outcomes of Treatment | 3 |
| Age Differences | 2 |
| Comparative Analysis | 2 |
| More ▼ | |
Source
| Journal of Attention Disorders | 4 |
| Journal of the American… | 2 |
| Journal of the American… | 2 |
| Journal of American College… | 1 |
Author
Publication Type
| Journal Articles | 9 |
| Reports - Research | 6 |
| Reports - Evaluative | 2 |
| Reports - Descriptive | 1 |
Education Level
| Elementary Education | 1 |
| Higher Education | 1 |
| Postsecondary Education | 1 |
Audience
Location
| France | 1 |
Laws, Policies, & Programs
Assessments and Surveys
| Sensation Seeking Scale | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkAntshel, Kevin M.; Parascandola, Theresa; Taylor, Lea E.; Faraone, Stephen V. – Journal of American College Health, 2021
Objective: The prevalence of stimulant medication misuse is rising in college students. Motivations to use stimulant medications differ from motivation to use other substances such as alcohol or cannabis. However, no previous research has examined the impact of achievement goal orientation on stimulant misuse in college students. Participants: 309…
Descriptors: College Students, Goal Orientation, Stimulants, Drug Abuse
Faraone, Stephen V. – Journal of Attention Disorders, 2012
Objective: An earlier meta-analysis of pediatric clinical trials indicated that lisdexamfetamine dimesylate (LDX) had a greater effect size than other stimulant medications. This work tested the hypothesis that the apparent increased efficacy was artifactual. Method: The authors assessed two potential artifacts: an unusually high precision of…
Descriptors: Stimulants, Intervals, Effect Size, Drug Therapy
Faraone, Stephen V.; Lecendreux, Michel; Konofal, Eric – Journal of Attention Disorders, 2012
Objective: A small literature suggests that ADHD may be associated with dysregulated growth, but this prior work primarily used clinically referred samples, so it faces difficulties of interpretation. The objective of this study is to sample the general French population for ADHD and evaluate if ADHD is associated with dysregulated growth.…
Descriptors: Psychopathology, Attention Deficit Hyperactivity Disorder, Foreign Countries, Telecommunications
Faraone, Stephen V.; Spencer, Thomas J.; Kollins, Scott H.; Glatt, Stephen J. – Journal of the American Academy of Child & Adolescent Psychiatry, 2010
Objective: To complete an exploratory uncontrolled study of the effects of lisdexamfetamine dimesylate (LDX) on growth of children treated for attention-deficit/hyperactivity disorder (ADHD). Method: Height, weight, and body mass index (BMI) from 281 children ages 6 to 13 years from longitudinal assessments up to 15 months were compared to norms…
Descriptors: Attention Deficit Hyperactivity Disorder, Disease Control, Body Composition, Diseases
Faraone, Stephen V.; Glatt, Stephen J.; Bukstein, Oscar G.; Lopez, Frank A.; Arnold, L. Eugene; Findling, Robert L. – Journal of Attention Disorders, 2009
Objective: Methylphenidate is a leading first-line treatment for ADHD (AD/HD). This stimulant has long been suspected to adversely affect sleeping patterns of treated individuals, especially children. There are few studies on the effects of recently developed longer-acting methylphenidate treatments, such as once-daily oral or transdermal…
Descriptors: Sleep, Attention Deficit Hyperactivity Disorder, Severity (of Disability), Drug Therapy
Faraone, Stephen V.; Biederman, Joseph; Morley, Christopher P.; Spencer, Thomas J. – Journal of the American Academy of Child & Adolescent Psychiatry, 2008
The article reviews existing literature on the effects of stimulant medications on the growth of children with attention-deficit/hyperactivity disorder. It concludes that treatment with stimulants in childhood results in moderate growth deficit in height and weight.
Descriptors: Stimulants, Hyperactivity, Attention Deficit Disorders, Body Weight
Biederman, Joseph; Spencer, Thomas J.; Wilens, Timothy E.; Prince, Jefferson B.; Faraone, Stephen V. – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
This article is a response to Dr. Steven E. Nissen's comments (Nissen, 2006) about attention deficit/hyperactivity disorder (ADHD) and its treatment with stimulant medications. In this article, the authors refute his arguments and provide accurate information. Here, they answer the questions, such as: (1) Do stimulants increase the risk for sudden…
Descriptors: Stimulants, Hyperactivity, Attention Deficit Disorders, Risk
Spencer, Thomas J.; Faraone, Stephen V.; Biederman, Joseph; Lerner, Marc; Cooper, Kimberly M.; Zimmerman, Brenda – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To investigate whether prolonged therapy with a long-acting stimulant affects growth in children with attention-deficit/hyperactivity disorder (ADHD). Method: One hundred seventy-eight children ages 6 to 13 years received OROS methylphenidate (OROS MPH, CONCERTA) for at least 21 months. Height and weight were measured monthly during the…
Descriptors: Body Height, Body Weight, Drug Therapy, Stimulants
Faraone, Stephen V.; Wigal, Sharon B.; Hodgkins, Paul – Journal of Attention Disorders, 2007
Objective: Compare observed and forecasted efficacy of mixed amphetamine salts extended release (MAS-XR; Adderall) with atomoxetine (Strattera) in ADHD children. Method: The authors analyze data from a randomized, double-blind, multicenter, parallel-group, forced-dose-escalation laboratory school study of children ages 6 to 12 with ADHD combined…
Descriptors: Laboratory Schools, Attention Deficit Disorders, Symptoms (Individual Disorders), Hyperactivity
